Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Neurocrine Biosciences (NBIX) Income from Continuing Operations (2016 - 2026)

Neurocrine Biosciences filings provide 16 years of Income from Continuing Operations readings, the most recent being 153700000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 49.08% to 153700000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 478600000.0, a 40.23% increase, with the full-year FY2025 number at 478600000.0, up 40.23% from a year prior.
  • Income from Continuing Operations hit 153700000.0 in Q4 2025 for Neurocrine Biosciences, down from 209500000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 209500000.0 in Q3 2025 to a low of 76600000.0 in Q1 2023.
  • Median Income from Continuing Operations over the past 5 years was 66750000.0 (2022), compared with a mean of 65685000.0.
  • Biggest five-year swings in Income from Continuing Operations: surged 1319.18% in 2022 and later crashed 651.08% in 2023.
  • Neurocrine Biosciences' Income from Continuing Operations stood at 7300000.0 in 2021, then surged by 1319.18% to 89000000.0 in 2022, then soared by 65.96% to 147700000.0 in 2023, then tumbled by 30.2% to 103100000.0 in 2024, then skyrocketed by 49.08% to 153700000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 153700000.0 (Q4 2025), 209500000.0 (Q3 2025), and 107500000.0 (Q2 2025) per Business Quant data.